Adrenaline-More questions than answers

Resuscitation

Volumn 81, Issue 6, 2010, Pages 637-638

  Böttiger, Bernd W ^a   Teschendorf, Peter ^a   Bernhard, Michael ^b   Nolan, Jerry ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b KLINIKUM FULDA   (Germany)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ATROPINE;

ACUTE HEART INFARCTION; CLINICAL TRIAL; EDITORIAL; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; HEALTH CARE QUALITY; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL RATE; VASCULAR ACCESS;

ADVANCED CARDIAC LIFE SUPPORT; CARDIOPULMONARY RESUSCITATION; EPINEPHRINE; HUMANS; INJECTIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952890772     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.03.024     Document Type: Editorial

References (6)

1. Nolan J.P., Deakin C.D., Soar J., et al. European Resuscitation Council Guidelines for Resuscitation 2005 Section 4. Adult advanced life support. Resuscitation 2005, 67(Suppl. 1):S39-S86.
2. Olasveengen T.M., Sunde K., Brunborg C., et al. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 2009, 302:2222-2229.
3. Nolan J.P., Neumar R.W., Adrie C., et al. Post-Cardiac Arrest Syndrome. Epidemiology, pathophysiology, treatment, and prognostication. A Consensus Statement from the International Liaison Committee on Resuscitation, the American Heart Association Emergency Cardiovascular Care Committee, the Council on Cardiovascular Surgery and Anesthesia, the Council on Cardiopulmonary, Perioperative, and Critical Care, the Council on Clinical Cardiology, and the Stroke Council. Resuscitation 2008, 79:350-379.
4. Laver S., Farrow C., Turner D., Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128.
5. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 1992;28:753-70.
6. Hennekens C.H., O'Donnell C.J., Ridker P.M., et al. Current issues concerning thrombolytic therapy for acute myocardial infarction. JAMA 1995, 25(7 Suppl.):18S-22S.